Blackstone and TPG have announced their plan to acquire medtech company Hologic for a staggering $18.3 billion, marking a significant move in the healthcare sector. This acquisition is expected to enhance Hologic's capabilities and expand its reach in the medical technology market, which is crucial for advancing healthcare solutions. The deal reflects growing confidence in the medtech industry and highlights the potential for innovation and growth in this vital sector.

Blackstone and TPG are set to acquire Hologic, a leading women's health company, for up to $18.3 billion, paying $76 per share in cash. This acquisition is significant as it highlights the growing investment in women's health and the potential for innovation in this sector, which could lead to improved healthcare solutions for women.

Blackstone and TPG are set to acquire Hologic, a leading women's health company, for up to $18.3 billion, paying $76 per share in cash. This acquisition is significant as it highlights the growing investment in women's health and the potential for innovation in this sector, which could lead to improved healthcare solutions for women.

Blackstone and TPG have struck a significant deal to acquire Hologic for up to $18.3 billion, marking a notable moment in the thriving private equity landscape. This acquisition highlights the growing interest in the medical device sector and reflects the robust activity in mergers and acquisitions, which is crucial for innovation and growth in healthcare.